Shenzhen Weiguang Biological Products Co., Ltd. (002880.SZ)

CNY 30.45

(-3.27%)

Market Cap (In CNY)

6.9 Billion

Revenue (In CNY)

1.04 Billion

Net Income (In CNY)

218.65 Million

Avg. Volume

1.94 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
22.05-36.3
PE
27.68
EPS
1.1
Beta Value
0.099
ISIN
CNE100002Q58
CUSIP
-
CIK
-
Shares
226800000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Caiping Guo
Employee Count
-
Website
https://www.szwg.com
Ipo Date
2017-06-16
Details
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human albumin, intravenous immunoglobulin (pH4), freeze-dried intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, histamine human immunoglobulin, and human fibrinogen, as well as a total of 9 varieties and 21 specifications. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.